Abstract | AIMS: METHODS: We searched MEDLINE, EMBASE, and Cochrane Library database for randomized controlled trials. Researches which reported the change in weight loss, blood glucose, and blood lipid levels were included. RESULTS: A total of 9 studies with 734 patients with diabetes were included. Pooled results suggested that LCD had a significantly effect on HbA1c level (WMD: -0.44; 95% CI: -0.61, -0.26; P=0.00). For cardiovascular risk factors, the LCD intervention significantly reduced triglycerides concentration (WMD: -0.33; 95% CI: -0.45, -0.21; P=0.00) and increased HDL cholesterol concentration (WMD: 0.07; 95% CI: 0.03, 0.11; P=0.00). But the LCD was not associated with decreased level of total cholesterol and LDL cholesterol. Subgroup analyses indicated that short term intervention of LCD was effective for weight loss (WMD: -1.18; 95% CI: -2.32, -0.04; P=0.04). CONCLUSIONS:
|
Authors | Yan Meng, Hao Bai, Shijun Wang, Zhaoping Li, Qian Wang, Liyong Chen |
Journal | Diabetes research and clinical practice
(Diabetes Res Clin Pract)
Vol. 131
Pg. 124-131
(Sep 2017)
ISSN: 1872-8227 [Electronic] Ireland |
PMID | 28750216
(Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
|
Copyright | Copyright © 2017. Published by Elsevier B.V. |
Topics |
- Diabetes Mellitus, Type 2
(therapy)
- Diet, Carbohydrate-Restricted
(methods)
- Humans
- Randomized Controlled Trials as Topic
- Risk Factors
- Weight Loss
(physiology)
|